Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMC 2193169)

Published in J Exp Med on April 03, 2000

Authors

G P Shi1, R A Bryant, R Riese, S Verhelst, C Driessen, Z Li, D Bromme, H L Ploegh, H A Chapman

Author Affiliations

1: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Harvard Medical School, Boston, Massachusetts 02115, USA.

Articles citing this

ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet (2003) 3.12

Lysosomal cysteine proteases: facts and opportunities. EMBO J (2001) 3.06

Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A (2001) 1.95

Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med (2002) 1.64

Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis (2010) 1.25

Chronic inflammation and asthma. Mutat Res (2009) 1.22

Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med (2001) 1.21

Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am J Respir Crit Care Med (2008) 1.16

Importance of lysosomal cysteine proteases in lung disease. Respir Res (2000) 1.13

Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response. Infect Immun (2001) 1.10

Endolysosomal proteases and their inhibitors in immunity. Nat Rev Immunol (2009) 1.10

Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J Clin Invest (2002) 1.09

Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages. J Exp Med (2003) 1.08

Cathepsins mediate tumor metastasis. World J Biol Chem (2013) 1.07

Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc Natl Acad Sci U S A (2003) 1.06

Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy. Int J Exp Pathol (2004) 1.04

Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J Clin Invest (2003) 1.04

Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol Cell Biol (2006) 1.02

The clinical significance of cathepsin S expression in human astrocytomas. Am J Pathol (2003) 0.98

Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis? Future Med Chem (2009) 0.95

Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer (2015) 0.89

Cathepsin G: roles in antigen presentation and beyond. Mol Immunol (2009) 0.89

Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells. J Immunol (2009) 0.88

Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm. Clin Rev Bone Miner Metab (2011) 0.86

Prss16 is not required for T-cell development. Mol Cell Biol (2005) 0.84

MHC class II antigen presentation by dendritic cells regulated through endosomal sorting. Cold Spring Harb Perspect Biol (2013) 0.83

Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice. PLoS One (2010) 0.83

Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells. Front Immunol (2014) 0.83

Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells. Mol Biol Cell (2008) 0.83

Proteases: essential actors in processing antigens and intracellular toll-like receptors. Front Immunol (2013) 0.81

Biochemical, transcriptomic and proteomic analyses of digestion in the scorpion Tityus serrulatus: insights into function and evolution of digestion in an ancient arthropod. PLoS One (2015) 0.80

Molecular mechanism and cellular function of MHCII ubiquitination. Immunol Rev (2015) 0.79

Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease. Immunology (2005) 0.78

The expression and activity of cathepsins D, H and K in asthmatic airways. PLoS One (2013) 0.78

Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target. Front Immunol (2015) 0.77

The protease cathepsin L regulates Th17 cell differentiation. J Autoimmun (2015) 0.76

Using the social amoeba Dictyostelium to study the functions of proteins linked to neuronal ceroid lipofuscinosis. J Biomed Sci (2016) 0.75

The Other Function: Class II-Restricted Antigen Presentation by B Cells. Front Immunol (2017) 0.75

Role of Cathepsins in Mycobacterium tuberculosis Survival in Human Macrophages. Sci Rep (2016) 0.75

Articles cited by this

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell (1994) 6.92

The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med (1990) 6.19

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66

Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol (1994) 4.29

Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science (1998) 3.98

Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature (1995) 3.40

Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol (1997) 3.24

Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity (1999) 3.01

Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity (1996) 2.93

The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (1995) 2.90

Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem (1995) 2.70

Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J Exp Med (1998) 2.45

Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell (1996) 2.32

How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol (1995) 2.24

Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity (1999) 2.14

Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem (1992) 2.13

DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity (1995) 2.10

Antigen presentation and T cell development in H2-M-deficient mice. Science (1996) 2.07

Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell (1998) 1.86

Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest (1998) 1.76

Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J Cell Biol (1999) 1.58

Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorg Med Chem (1999) 1.58

Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J Biol Chem (1994) 1.49

Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett (1995) 1.42

Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med (1997) 1.25

Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location. J Biol Chem (1998) 1.25

The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide. Biochemistry (1999) 1.17

Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J Immunol (1998) 1.14

In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets. J Immunol (1997) 1.10

The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens. Eur J Immunol (1998) 1.05

Human cathepsin F. Molecular cloning, functional expression, tissue localization, and enzymatic characterization. J Biol Chem (1998) 1.04

Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett (1998) 1.03

Human cathepsin X: A cysteine protease with unique carboxypeptidase activity. Biochemistry (1999) 1.03

Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J Biol Chem (1999) 0.99

Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors. J Med Chem (1996) 0.94

Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. FEBS Lett (1997) 0.93

High level expression and crystallization of recombinant human cathepsin S. Protein Sci (1996) 0.88

Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes. J Allergy Clin Immunol (1999) 0.87

Exercise suppresses macrophage antigen presentation. J Appl Physiol (1985) (1999) 0.85

Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen, II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent. Immunology (1998) 0.83

Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen. Biochem Biophys Res Commun (1999) 0.82

Influence of acute exposure to cigarette smoke on the alveolar macrophage system. J Lab Clin Med (1977) 0.80

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

The genome sequence of Drosophila melanogaster. Science (2000) 74.32

Comparative genomics of the eukaryotes. Science (2000) 26.62

The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 8.25

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98

Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (1996) 7.90

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73

Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med (1999) 6.27

Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (1991) 5.90

The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87

Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell (1981) 5.81

Viral subversion of the immune system. Annu Rev Immunol (2000) 5.76

Convergent domestication of cereal crops by independent mutations at corresponding genetic Loci. Science (1995) 5.52

Inhibition of JNK activation through NF-kappaB target genes. Nature (2001) 5.03

TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell (1992) 4.76

A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75

Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered (2002) 4.64

Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature (1997) 4.59

Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol (1986) 4.30

Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science (1996) 4.22

The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell (1990) 4.18

Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16

Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med (1998) 3.83

Synthesis and fungicidal activity against Rhizoctonia solani of 2-alkyl (Alkylthio)-5-pyrazolyl-1,3,4-oxadiazoles (Thiadiazoles). J Agric Food Chem (2000) 3.78

Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem (1996) 3.63

Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem (1996) 3.63

Regulation of integrin function by the urokinase receptor. Science (1996) 3.56

Isolation and characterization of the intracellular MHC class II compartment. Nature (1994) 3.50

Isoform-specific 3'-untranslated sequences sort alpha-cardiac and beta-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J Cell Biol (1993) 3.49

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell (1990) 3.44

A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J (2001) 3.42

Uvomorulin: a nonintegral membrane protein of early mouse embryo. Proc Natl Acad Sci U S A (1983) 3.42

Cell-free translation of the mRNAs for the heavy and light chains of HLA-A and HLA-B antigens. Proc Natl Acad Sci U S A (1979) 3.29

Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest (1998) 3.17

Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17

Single-cell electroporation for gene transfer in vivo. Neuron (2001) 3.15

The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol (1987) 3.09

Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med (1990) 3.04

RAG mutations in human B cell-negative SCID. Science (1996) 3.03

Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity (1999) 3.01

Molecular cloning of a human histocompatibility antigen cDNA fragment. Proc Natl Acad Sci U S A (1980) 2.99

Macrophage tumor killing: influence of the local environment. Science (1977) 2.94

Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry (2009) 2.94

Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity (1996) 2.93

The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity (1997) 2.93

Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem (1994) 2.92

Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics (1994) 2.88

Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A (1999) 2.88

Effects of dog ownership in early childhood on immune development and atopic diseases. Clin Exp Allergy (2008) 2.86

Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol (1996) 2.86

Structural and magnetic phase diagram of CeFeAsO(1- x)F(x) and its relation to high-temperature superconductivity. Nat Mater (2008) 2.83

Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity (2001) 2.77

Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother (2001) 2.76

Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast. EMBO J (1998) 2.75

Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci U S A (1998) 2.75

Superconductivity at 41 K and its competition with spin-density-wave instability in layered CeO1-xFxFeAs. Phys Rev Lett (2008) 2.72

Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature (1987) 2.72

Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut (2000) 2.71

Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol (1978) 2.65

Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis (2000) 2.63

Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem (2000) 2.62

Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med (1997) 2.59

Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J (1996) 2.55

Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol (1995) 2.53

Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys (1999) 2.47

Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol (1996) 2.46

A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol (1999) 2.46

Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics (1996) 2.44

TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell (1993) 2.43

Health status by gastrointestinal diagnosis and abuse history. Gastroenterology (1996) 2.41

The vacB gene required for virulence in Shigella flexneri and Escherichia coli encodes the exoribonuclease RNase R. J Biol Chem (1998) 2.41

Mutations in the essential spindle checkpoint gene bub1 cause chromosome missegregation and fail to block apoptosis in Drosophila. J Cell Biol (1999) 2.41

Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol (1993) 2.40

Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism. J Biol Chem (2000) 2.39

The WD-40 repeat. FEBS Lett (1992) 2.37

Spontaneous breaking of time-reversal symmetry in the pseudogap state of a high-Tc superconductor. Nature (2002) 2.37

Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1995) 2.36

Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J (1998) 2.36

Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36

Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med (2000) 2.36

Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30

Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J (1998) 2.29

Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J (1996) 2.26

Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J (2000) 2.24

How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol (1995) 2.24

Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science (1999) 2.21

Hypoxia inducible factors in cancer stem cells. Br J Cancer (2010) 2.21

Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 2.20

The alpha chain of the T cell antigen receptor is degraded in the cytosol. Immunity (1997) 2.20

Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci (2001) 2.19

Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18

Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J Cell Biol (1998) 2.16

Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem (1992) 2.13

Interactions between biofilms and the environment. FEMS Microbiol Rev (1997) 2.13

HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol (1990) 2.12

Microtubule binding to Smads may regulate TGF beta activity. Mol Cell (2000) 2.09